Abstract
Coronavirus disease 2019 (COVID-19) spread throughout the world and caused hundreds of thousands of deaths. However, the pathogenesis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is poorly understood. This study retrospectively explores the pathogenesis of COVID-19 from clinical laboratory findings, taking disease progression into account. A single-centered, retrospective study included moderate (n=76) and severe COVID-19 cases (n=22). Laboratory findings from blood routine examination and hepatorenal function tests were evaluated. Disease progression was indicated by the oxygenation index (OI). Results showed that age is a risk factor for progression. Lymphocytopenia, neutrophilia, and decreased liver/kidney function occurred in severe patients on admission. Crucially, lymphocytopenia and neutrophilia deteriorated at the lowest OI timepoint in severe patients. OI was associated with lymphocyte and neutrophil ratios, suggesting these markers are central to COVID-19 pathogenesis.
Introduction
In the early months of the pandemic, clinicians observed that COVID-19 patients often experienced a sudden, dramatic decline in lung function, leading to Acute Respiratory Distress Syndrome (ARDS). However, the precise timing of the "immune storm" relative to this respiratory failure wasn't fully understood. Most studies at the time focused on patient data at the point of hospital admission or discharge. This paper addresses the gap by focusing on the nadir—the absolute worst point of a patient's illness—to see how blood markers correlate with the most critical phase of the disease. By identifying which laboratory findings track with the lowest oxygenation levels, the authors aimed to pinpoint the biological hallmarks of severe progression.
Methods and Datasets
The researchers conducted a single-centered, retrospective study at Taizhou Hospital in Zhejiang Province, China. They analyzed 98 confirmed COVID-19 patients, categorized into "moderate" (n=76) and "severe" (n=22) groups based on respiratory rate and oxygen saturation.
The study's novel approach was using the Oxygenation Index (PaO2/FiO2) as the primary indicator of disease progression. They tracked laboratory findings (blood counts, liver function, kidney function) across three specific timepoints: admission, the lowest Oxygenation Index timepoint (the "sickest" moment), and discharge. Linear regression was used to identify which factors, such as age or comorbidities, most heavily influenced the drop in oxygenation.
Key Results
The most striking finding is that lymphocytopenia and neutrophilia aren't just present in severe cases; they significantly deteriorate in lockstep with the Oxygenation Index. When the lungs are at their weakest, the immune system is at its most imbalanced.
In severe patients, the lymphocyte ratio plummeted from 23.6% at admission to just 11.55% at the lowest oxygenation point. Simultaneously, the neutrophil ratio climbed to over 81%. This suggests a "double whammy": a loss of the cells needed to fight the virus (lymphocytes) and an explosion of cells that cause collateral inflammatory damage (neutrophils).
Key statistical findings include:
- Immune Markers: At the lowest OI point, severe patients had significantly higher white-cell counts (8.05 vs 6.0 x 10⁹/L) and neutrophil ratios (81.25% vs 66.1%) compared to moderate cases.
- Correlation: The Oxygenation Index showed a strong correlation with the lymphocyte and neutrophil ratios, serving as a reliable predictor of the underlying immune storm.
- Organ Function: Severe patients showed poorer liver and kidney function (measured by ALT, AST, and creatinine clearance) at admission, though these markers improved gradually even as respiratory function dipped.
- Treatment Impact: Severe patients were significantly more likely to receive glucocorticoids (77.3% vs 5.3%) and immunoglobulin (63.6% vs 2.6%) to combat the immune deterioration.
Discussion and Conclusion
The study concludes that lymphocytopenia and neutrophilia, which deteriorate during the progression of severe cases, are the main pathogenesis of COVID-19. The Oxygenation Index presented potentiality as a predictor for disease progression.
While the study is limited by a small sample size (n=22 severe cases) and its retrospective nature, it highlights the importance of monitoring the Oxygenation Index. The authors suggest that early intervention to stabilize lymphocyte counts could prevent patients from reaching that critical respiratory nadir. Larger prospective studies are recommended to validate these findings and explore therapeutic interventions targeting these immune imbalances.
Summary updated